MIR7854

Across TCGA pan-cancer cohorts, MIR7854 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR7854 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR7854 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR7854 expression acts as an unfavorable survival marker, although some lineages such as MESO and LAML show a favorable association.

THCA, ACC, and DLBC are the cancer types where MIR7854 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.579	0.948	<.001	123	view →
ACC	OS	Tertile	All	0.551	0.904	<.001	105	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	54	view →
TGCT	DFS	Tertile	II,III,IV	0.518	0.996	<.001	54	view →
MESO	DFS	Tertile	All	0.502	0.168	.008	42	view →
UCEC	OS	Tertile	All	0.399	0.702	<.001	36	view →
ESCA	OS	Median	All	0.572	0.778	.001	30	view →
THYM	DFS	Tertile	All	0.049	0.811	.005	18	view →
LAML	DFS	Quartile	All	0.812	0.319	<.001	18	view →
UCS	OS	Tertile	All	0.915	0.637	.042	6	view →
STAD	DFS	Median	II,III,IV	0.597	0.332	.030	5	view →
HNSC	DFS	Median	III,IV	0.524	0.646	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR7854–THCA (OS)

Open the THCA breakdown →